Abstract | OBJECTIVES: PATIENTS: RESULTS: At the time of this writing, the patient has good primary hepatic function, and, although not receiving specific medication, shows no signs of pancytopenia. Anticoagulation with low-dose acetylsalicylic acid was initiated. Forty-eight months after the transplant, there are no signs of thromboembolic complications affecting the liver. CONCLUSIONS:
|
Authors | Suleyman Yedibela, Werner Hohenberger |
Journal | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
(Exp Clin Transplant)
Vol. 6
Issue 3
Pg. 180-3
(Sep 2008)
ISSN: 1304-0855 [Print] Turkey |
PMID | 18954293
(Publication Type: Case Reports, Journal Article)
|
Topics |
- Budd-Chiari Syndrome
(etiology, surgery)
- Follow-Up Studies
- Hemoglobinuria, Paroxysmal
(complications)
- Humans
- Liver Transplantation
- Male
- Treatment Outcome
- Young Adult
|